Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, |
RCV005428402 | SCV006094154 | benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2025-02-19 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
| Ambry Genetics | RCV001523980 | SCV002621895 | likely benign | Hereditary cancer-predisposing syndrome | 2019-10-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Color Diagnostics, |
RCV001523980 | SCV001733726 | likely benign | Hereditary cancer-predisposing syndrome | 2020-08-03 | criteria provided, single submitter | clinical testing |